149 related articles for article (PubMed ID: 31773842)
21. Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Lee RH; Salesky M; Benjamin T; El-Sayed IH; George JR; Ha PK; Ryan WR; Heaton CM
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):704-711. PubMed ID: 34182836
[TBL] [Abstract][Full Text] [Related]
22. Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma.
Yan EZ; Wahle BM; Massa ST; Zolkind P; Paniello RC; Pipkorn P; Jackson RS; Rich JT; Puram SV; Mazul AL
Cancer Med; 2023 Apr; 12(8):9976-9987. PubMed ID: 36847063
[TBL] [Abstract][Full Text] [Related]
23. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
Wang MB; Liu IY; Gornbein JA; Nguyen CT
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
[TBL] [Abstract][Full Text] [Related]
24. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
[TBL] [Abstract][Full Text] [Related]
25. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
[TBL] [Abstract][Full Text] [Related]
26. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
[TBL] [Abstract][Full Text] [Related]
27. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and meta-analysis of racial survival disparities among oropharyngeal cancer cases by HPV status.
Stein E; Lenze NR; Yarbrough WG; Hayes DN; Mazul A; Sheth S
Head Neck; 2020 Oct; 42(10):2985-3001. PubMed ID: 32632953
[TBL] [Abstract][Full Text] [Related]
29. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
[TBL] [Abstract][Full Text] [Related]
30. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
Lim MY; Dahlstrom KR; Sturgis EM; Li G
Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
[TBL] [Abstract][Full Text] [Related]
32. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
33. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study.
De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP
Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252
[TBL] [Abstract][Full Text] [Related]
34. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy in Metastatic Oropharyngeal Cancer.
Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
[TBL] [Abstract][Full Text] [Related]
36. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
37. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
[TBL] [Abstract][Full Text] [Related]
39. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
Anayannis NV; Schlecht NF; Belbin TJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
